Müller-Hermelink HK - Search Results

1

Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system.

Beutner U, Lorenz U, Illert B, Rott L, Timmermann W, Vollmers HP, Müller-Hermelink HK, Thiede A, Ulrichs K. Beutner U, et al. Oncol Rep. 2008 Mar;19(3):761-9. Oncol Rep. 2008. PMID: 18288413

2

[Adjuvant immunotherapy of stomach carcinoma with antibody-induced apoptosis].

Vollmers HP, Timmermann W, Hensel F, Illert B, Thiede A, Müller-Hermelink HK. Vollmers HP, et al. Zentralbl Chir. 2000;125 Suppl 1:37-40. Zentralbl Chir. 2000. PMID: 10929645 Clinical Trial. German.

3

Tumor-specific apoptosis induced by the human monoclonal antibody SC-1: a new therapeutical approach for stomach cancer.

Vollmers HP, Hensel F, Hermann R, Dämmrich J, Wozniak E, Gessner P, Herrmann B, Zimmermann U, Müller-Hermelink HK. Vollmers HP, et al. Oncol Rep. 1998 Jan-Feb;5(1):35-40. doi: 10.3892/or.5.1.35. Oncol Rep. 1998. PMID: 9458378

4

Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results.

Vollmers HP, Zimmermann U, Krenn V, Timmermann W, Illert B, Hensel F, Hermann R, Thiede A, Wilhelm M, Rückle-Lanz H, Reindl L, Müller-Hermelink HK. Vollmers HP, et al. Oncol Rep. 1998 May-Jun;5(3):549-52. doi: 10.3892/or.5.3.549. Oncol Rep. 1998. PMID: 9538151 Clinical Trial.

5

CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1.

Brändlein S, Pohle T, Vollmers C, Wozniak E, Ruoff N, Müller-Hermelink HK, Vollmers HP. Brändlein S, et al. Oncol Rep. 2004 Apr;11(4):777-84. Oncol Rep. 2004. PMID: 15010872

6

SC-1, a functional human monoclonal antibody against autologous stomach carcinoma cells.

Vollmers HP, O'Connor R, Müller J, Kirchner T, Müller-Hermelink HK. Vollmers HP, et al. Cancer Res. 1989 May 1;49(9):2471-6. Cancer Res. 1989. PMID: 2706635

7

A novel proliferation-associated variant of CFR-1 defined by a human monoclonal antibody.

Hensel F, Brändlein S, Eck M, Schmidt K, Krenn V, Kloetzer A, Bachi A, Mann M, Müller-Hermelink HK, Vollmers HP. Hensel F, et al. Lab Invest. 2001 Aug;81(8):1097-108. doi: 10.1038/labinvest.3780322. Lab Invest. 2001. PMID: 11502861 Free article.

8

Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis.

Hensel F, Hermann R, Brändlein S, Krenn V, Schmausser B, Geis S, Müller-Hermelink HK, Vollmers HP. Hensel F, et al. Lab Invest. 2001 Nov;81(11):1553-63. doi: 10.1038/labinvest.3780369. Lab Invest. 2001. PMID: 11706063 Free article.

9

Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody.

Vollmers HP, Dämmrich J, Ribbert H, Wozniak E, Müller-Hermelink HK. Vollmers HP, et al. Cancer. 1995 Aug 15;76(4):550-8. doi: 10.1002/1097-0142(19950815)76:4<550::aid-cncr2820760403>3.0.co;2-h. Cancer. 1995. PMID: 8625146

10

A rapid method for purification of monoclonal human IgM from mass culture.

Vollmers HP, Wozniak E, Stepien-Bötsch E, Zimmermann U, Müller-Hermelink HK. Vollmers HP, et al. Hum Antibodies Hybridomas. 1996;7(1):37-41. Hum Antibodies Hybridomas. 1996. PMID: 8886835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters